Clinical Trial Update: Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating irinotecan followed by fluorouracil and leucovorin in patients with stage III/IV colorectal cancer, carcinoma of unknown prima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary
• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Carcinoma of Unknown Primary, Colorectal Cancer | Phase 2 | Status: COMPLETED